SCHEMBL2233197

SCHEMBL2233197

C/C(=C(/CC[Si](C)(C)C)C(=O)O)c1cc(C)c(Oc2ccc(OCc3ccc(C)cc3)cn2)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.38
ACACB O00763 3/20 0.37
ACACA Q13085 2/20 0.37
HRH3 Q9Y5N1 2/20 0.36
ALOX5 P09917 1/20 0.36
ALOX5AP P20292 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
FFAR1 O14842 4/20 0.35
PARP10 Q53GL7 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
LMNA P02545 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
GRM2 Q14416 1/20 0.33
CYSLTR1 Q9Y271 1/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2233202 1.00 MAOB (0.38) MAOBACACBACACAHRH3ALOX5
SCHEMBL13582311 0.89 MAOB (0.42) MAOBACACBACACAHRH3THRA
SCHEMBL13582309 0.89 MAOB (0.42) MAOBACACBACACAHRH3THRA
SCHEMBL13582306 0.89 MAOB (0.42) MAOBACACBACACAHRH3THRA
SCHEMBL2231827 0.87 MAOB (0.41) MAOBACACBACACAALOX5ALOX5AP
SCHEMBL2231836 0.87 MAOB (0.41) MAOBACACBACACAALOX5ALOX5AP
SCHEMBL16161742 0.84 KDM4E (0.32) ACACBTHRATHRB
SCHEMBL2233200 0.83 ALOX5 (0.35) MAOBACACBACACAALOX5ALOX5AP
SCHEMBL2236373 0.82 MAOB (0.42) MAOBACACBACACATHRATHRB
SCHEMBL2236378 0.82 MAOB (0.42) MAOBACACBACACATHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011093524-A1 DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-04 WO disclosed